Featured Research

from universities, journals, and other organizations

National Jewish Receives NIH Grant To Study Fibrotic Lung Disease

Date:
June 23, 1997
Source:
National Jewish Medical And Research Center
Summary:
The National Heart, Lung and Blood Institute at the National Institutes of Health have awarded National Jewish Medical and Research Center a $9 million Specialized Center of Research grant to study the pathogenesis and treatment of pulmonary fibrosis.

CONTACT: Jordan Gruener
(303) 398-1002


National Jewish Medical and Research Center Receives
$9 Million Grant From NIH to Study Fibrotic Lung Disease


The National Heart, Lung and Blood Institute at the National Institutes of Health have awarded National Jewish Medical and Research Center a $9 million Specialized Center of Research grant to study the pathogenesis and treatment of pulmonary fibrosis.

The grant is $1.8 million a year for 5 years. This work will be part of the clinical and research program of the Pulmonary and Critical Care Division of the University of Colorado Health Sciences Center.
"We need to learn more about the basic mechanisms of fibrosis," said Robert Mason, M.D., a National Jewish physician and principal investigator of the study. "We’re focusing on inflammation and growth factors as regulators of the fibrotic response."


People with pulmonary fibrosis, also known as interstitial lung disease, generally suffer from cough. Scarring in the lungs, caused by the disease, makes the lungs stiff and causes shortness of breath.


"We’re trying to prevent continued scar formation in the lungs," Dr. Mason said. "Pulmonary fibrosis is a devastating disease, like cancer, with a high mortality rate."
National Jewish will continue its basic studies on the mechanism of pulmonary fibrosis and initiate clinical trials aimed at limiting the fibrotic response. Kevin Brown, M.D., of National Jewish, will head the clinical patient assessment and be responsible for controlled clinical trials. This work will be performed in collaboration with physicians and investigators at the University of Colorado.

National Jewish researchers are conducting four interstitial lung disease research projects. The research projects include:

• The role of T cells in inducing pulmonary fibrosis
• Interactions between the epithelium and the mesenchyme—a network of cells—during lung injury and treatment
• Regulation of the paroduction of fibrogenic growth factors by macrophages
• A clinical trial using interferon gamma to control inflammation in the lungs and to control the fibrotic response


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "National Jewish Receives NIH Grant To Study Fibrotic Lung Disease." ScienceDaily. ScienceDaily, 23 June 1997. <www.sciencedaily.com/releases/1997/06/970623135338.htm>.
National Jewish Medical And Research Center. (1997, June 23). National Jewish Receives NIH Grant To Study Fibrotic Lung Disease. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/1997/06/970623135338.htm
National Jewish Medical And Research Center. "National Jewish Receives NIH Grant To Study Fibrotic Lung Disease." ScienceDaily. www.sciencedaily.com/releases/1997/06/970623135338.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins